Chi-Ming Li

829 total citations
8 papers, 667 citations indexed

About

Chi-Ming Li is a scholar working on Molecular Biology, Organic Chemistry and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Chi-Ming Li has authored 8 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Chi-Ming Li's work include Genetic Syndromes and Imprinting (2 papers), Renal and related cancers (2 papers) and Cancer-related gene regulation (2 papers). Chi-Ming Li is often cited by papers focused on Genetic Syndromes and Imprinting (2 papers), Renal and related cancers (2 papers) and Cancer-related gene regulation (2 papers). Chi-Ming Li collaborates with scholars based in United States, South Korea and Canada. Chi-Ming Li's co-authors include Benjamin Tycko, Audrey Ahn, Alan Soo Beng Khoo, Marina Vorontchikhina, Anthony M.C. Brown, Nancy L. Parmalee, Jan Kitajewski, Dritan Agalliu, Vundavalli V. Murty and Martha Salas and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and American Journal Of Pathology.

In The Last Decade

Chi-Ming Li

8 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chi-Ming Li United States	8	500	115	78	76	69	8	667
Dorota Piekutowska‐Abramczuk Poland	17	773 1.5×	181 1.6×	34 0.4×	86 1.1×	52 0.8×	59	1.0k
Barry Robert United States	11	439 0.9×	50 0.4×	134 1.7×	53 0.7×	68 1.0×	12	627
Benson Lu United States	11	678 1.4×	155 1.3×	196 2.5×	41 0.5×	124 1.8×	13	827
Benjamin H. Fryer United States	8	343 0.7×	44 0.4×	63 0.8×	138 1.8×	93 1.3×	9	586
Jenny Watson Ireland	12	464 0.9×	64 0.6×	88 1.1×	191 2.5×	46 0.7×	22	708
Sally Metsuyanim Israel	15	701 1.4×	93 0.8×	225 2.9×	71 0.9×	76 1.1×	21	872
Cyril Legum Israel	18	354 0.7×	176 1.5×	81 1.0×	75 1.0×	78 1.1×	58	921
Mark J. McCabe United Kingdom	16	331 0.7×	259 2.3×	59 0.8×	100 1.3×	70 1.0×	22	707
Yoach Rais Israel	12	734 1.5×	147 1.3×	32 0.4×	92 1.2×	19 0.3×	16	954
Keiko Tadokoro Japan	14	633 1.3×	160 1.4×	53 0.7×	50 0.7×	29 0.4×	19	856

Countries citing papers authored by Chi-Ming Li

Since Specialization

Citations

This map shows the geographic impact of Chi-Ming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi-Ming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi-Ming Li more than expected).

Fields of papers citing papers by Chi-Ming Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi-Ming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi-Ming Li. The network helps show where Chi-Ming Li may publish in the future.

Co-authorship network of co-authors of Chi-Ming Li

This figure shows the co-authorship network connecting the top 25 collaborators of Chi-Ming Li. A scholar is included among the top collaborators of Chi-Ming Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi-Ming Li. Chi-Ming Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Beltran, Pedro J., Frank J. Calzone, Petia Mitchell, et al.. (2014). Ganitumab (AMG 479) Inhibits IGF-II–Dependent Ovarian Cancer Growth and Potentiates Platinum-Based Chemotherapy. Clinical Cancer Research. 20(11). 2947–2958. 41 indexed citations

2.

Li, Chi-Ming, Martha Salas, Nicole Schupf, et al.. (2006). Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21. BMC Medical Genetics. 7(1). 24–24. 71 indexed citations

3.

Agalliu, Dritan, Marina Vorontchikhina, Audrey Ahn, et al.. (2006). Wnt5a Signaling Induces Proliferation and Survival of Endothelial Cells In Vitro and Expression of MMP-1 and Tie-2. Molecular Biology of the Cell. 17(12). 5163–5172. 185 indexed citations

4.

Li, Chi-Ming, Martha Salas, Lorenzo Memeo, et al.. (2006). PEG10 Is a c-MYC Target Gene in Cancer Cells. Cancer Research. 66(2). 665–672. 80 indexed citations

5.

Yuan, Rui, Chi-Ming Li, Darrell J. Yamashiro, et al.. (2005). Genomic Profiling Maps Loss of Heterozygosity and Defines the Timing and Stage Dependence of Epigenetic and Genetic Events in Wilms' Tumors. Molecular Cancer Research. 3(9). 493–502. 58 indexed citations

6.

Li, Chi-Ming, Connie E. Kim, Jimmy Zhu, et al.. (2004). CTNNB1 Mutations and Overexpression of Wnt/β-Catenin Target Genes in WT1-Mutant Wilms' Tumors. American Journal Of Pathology. 165(6). 1943–1953. 111 indexed citations

7.

Li, Chi-Ming, Jae‐Ho Park, Xingxuan He, et al.. (1999). Molecular Cloning and Characterization of a Human cDNA and Gene Encoding a Novel Acid Ceramidase-like Protein. Genomics. 62(2). 232–241. 13 indexed citations

8.

Li, Chi-Ming, Jae‐Ho Park, Xingxuan He, et al.. (1999). The Human Acid Ceramidase Gene (ASAH): Structure, Chromosomal Location, Mutation Analysis, and Expression. Genomics. 62(2). 223–231. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact